A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects
Clinical trial NCT03554993 · COMPLETED
Trial details
- NCT number
- NCT03554993
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2019-07-03
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.